Rubin Jonathan
Reporting owner on Forms 3, 4 and 5, CIK 1836067.
Rubin Jonathan reported on 2 issuers in 4 filings, the latest a Form 4 filed 2026-11-04.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| SUPNCIK 1356576 | officer (SVP, Chief Medical Officer) | 2 | 2026-11-04 |
| Supernus, Inc. CIK 1625297 | officer (SVP, Chief Medical Officer) | 1 | 2026-11-04 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Supernus, Inc. Common Stock | 2026-11-02 | J other | +21,529 | $0 | 21,529 | Form 4 |
| Supernus, Inc. Employee Stock Option (right to buy), derivative | 2026-11-02 | J other | +23,101 | $0 | 23,101 | Form 4 |
| Supernus, Inc. Employee Stock Option (right to buy), derivative | 2026-11-02 | J other | +38,502 | $0 | 38,502 | Form 4 |
| Supernus, Inc. Employee Stock Option (right to buy), derivative | 2026-11-02 | J other | +38,502 | $0 | 38,502 | Form 4 |
| Supernus, Inc. Employee Stock Option (right to buy), derivative | 2026-11-02 | J other | +30,802 | $0 | 30,802 | Form 4 |
| Supernus, Inc. Employee Stock Option (right to buy), derivative | 2026-11-02 | J other | +38,502 | $0 | 38,502 | Form 4 |
| Supernus, Inc. Employee Stock Option (right to buy), derivative | 2026-11-02 | J other | +30,802 | $0 | 30,802 | Form 4 |
| Supernus, Inc. Employee Stock Option (right to buy), derivative | 2026-11-02 | J other | +20,791 | $0 | 20,791 | Form 4 |
| Supernus, Inc. Restricted Stock Units, derivative | 2026-11-02 | J other | +1,925 | $0 | 1,925 | Form 4 |
| Supernus, Inc. Restricted Stock Units, derivative | 2026-11-02 | J other | +3,850 | $0 | 3,850 | Form 4 |
| Supernus, Inc. Restricted Stock Units, derivative | 2026-11-02 | J other | +5,197 | $0 | 5,197 | Form 4 |
| Supernus, Inc. Restricted Stock Units, derivative | 2026-11-02 | J other | +4,620 | $0 | 4,620 | Form 4 |
| Supernus, Inc. Restricted Stock Units, derivative | 2026-11-02 | J other | +107,807 | $0 | 107,807 | Form 4 |
| Supernus, Inc. Restricted Stock Units, derivative | 2026-11-02 | J other | +2,695 | $0 | 2,695 | Form 4 |
| Supernus, Inc. Restricted Stock Units, derivative | 2026-11-02 | J other | +1,155 | $0 | 1,155 | Form 4 |
| Supernus, Inc. Restricted Stock Units, derivative | 2026-11-02 | J other | +1,155 | $0 | 1,155 | Form 4 |
| Supernus, Inc. Restricted Stock Units, derivative | 2026-11-02 | J other | +1,540 | $0 | 1,540 | Form 4 |
| Supernus, Inc. Restricted Stock Units, derivative | 2026-11-02 | J other | +1,886 | $0 | 1,886 | Form 4 |
| Supernus, Inc. Restricted Stock Units, derivative | 2026-11-02 | J other | +1,886 | $0 | 1,886 | Form 4 |
| Supernus, Inc. Restricted Stock Units, derivative | 2026-11-02 | J other | +1,617 | $0 | 1,617 | Form 4 |
| SUPN · CIK 1356576Common Stock | 2026-11-02 | J other | -13,979 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Employee Stock Option (Right to Buy), derivative | 2026-11-02 | J other | -15,000 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Employee Stock Option (Right to Buy), derivative | 2026-11-02 | J other | -25,000 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Employee Stock Option (Right to Buy), derivative | 2026-11-02 | J other | -25,000 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Employee Stock Option (Right to Buy), derivative | 2026-11-02 | J other | -20,000 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Employee Stock Option (Right to Buy), derivative | 2026-11-02 | J other | -25,000 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Employee Stock Option (Right to Buy), derivative | 2026-11-02 | J other | -20,000 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Employee Stock Option (Right to Buy), derivative | 2026-11-02 | J other | -13,500 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Restricted Stock Unit, derivative | 2026-11-02 | J other | -70,000 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Restricted Stock Unit, derivative | 2026-11-02 | J other | -3,000 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Restricted Stock Unit, derivative | 2026-11-02 | J other | -3,375 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Restricted Stock Unit, derivative | 2026-11-02 | J other | -2,500 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Restricted Stock Unit, derivative | 2026-11-02 | J other | -1,250 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Performance Share Unit, derivative | 2026-11-02 | J other | -4,250 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Performance Share Unit, derivative | 2026-11-02 | J other | -3,500 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Restricted Stock Unit, derivative | 2026-10-30 | A granted | +70,000 | $0 | 70,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001104659-26-122824 | Supernus, Inc. | 2026-11-04 | ||
| Form 3 0001104659-26-122732 | Supernus, Inc. | 2026-11-04 | ||
| Form 4 0001836067-26-000014 | SUPERNUS PHARMACEUTICALS, INC. | 2026-11-04 | ||
| Form 4 0001836067-26-000012 | SUPERNUS PHARMACEUTICALS, INC. | 2026-11-02 |